Nevertheless, melanoma is characteristically a high mutational burden tumour type [34], and since gene length and mutation frequency are usually correlated, it is plausible that CDH23 mutations do not constitute a proper marker of prognostic value and its high mutation frequency derives from large size of this gene (>419,000 bases). Here, CDH23 is linked to melanoma.